US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 26, 2020

Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 11, 2022

    Judge Issues Mixed Ruling In Salix, Norwich Patent Row

    A Delaware federal judge has found that Norwich Pharmaceuticals Inc.'s proposed generic version of a treatment for a neurological disorder linked to liver disease would induce infringement of various Salix Pharmaceuticals Ltd. patents, but also determined that claims in other Salix patents on the product were not valid.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login